Moloboco, Sheperedine Mae M.

HRN: 24-16-63  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2024
CEFUROXIME 500MG (TAB)
09/13/2024
09/19/2024
ORAL
500mg
2 Times A Day
Premature Rupture Of Membranes
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes